ameBB073593 SequenceACA GTG GGT CTT and 14 more items

Integrated DNA Technologies Inc. has been awarded a contract by Virginia Commonwealth University (VCU) with an effective date of October 6, 2026, and a cumulative contract value of $164.00. The contract encompasses the delivery of fifteen synthetic DNA sequences, each ordered as a single unit and delivered to VCU Procurement in Virginia. The line items consist of various engineered DNA constructs with specific genetic sequences, including components such as fluorescent protein variants (GFP), antibiotic resistance markers (Kan, flgB), and restriction enzyme recognition sites (AvrII, XhoI, SalI). Individual unit prices range from $6.05 to $17.86 per sequence.

The deliverables appear to support molecular biology and genetic engineering research applications at Virginia Commonwealth University. Each DNA sequence construct is tailored for specific laboratory purposes, as indicated by nomenclature referencing genetic markers and functional elements commonly used in synthetic biology protocols. All items are designated for delivery to VCU Procurement within the Commonwealth of Virginia, with no distinct performance period specified beyond the award date. This procurement represents a low-value acquisition of specialty molecular biology materials for use in VCU's research operations.